Orexo Logo

Orexo

Develops pharmaceuticals and digital therapies for substance use and mental health.

ORX | ST

Overview

Corporate Details

ISIN(s):
SE0000736415 (+2 more)
LEI:
549300LJ5CCWDPTK9Z08
Country:
Sweden
Address:
Box 303, 751 05 UPPSALA

Description

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 08:00 Swedish 4.8 MB
2025-10-23 08:00 English 4.8 MB
2025-10-17 08:00
Orexo:s valberedning inför årsstämman 2026
Swedish 78.0 KB
2025-10-17 08:00
Orexo´s Nomination Committee for the Annual General Meeting 2026
English 77.7 KB
2025-10-06 15:35 Swedish 9.8 KB
2025-09-29 20:30
Orexo US Awarded USD 8 Million by BARDA for OX390 Development Partnership
English 86.4 KB
2025-09-29 20:30
Orexo US får SEK 75 miljoner från BARDA för utvecklingssamarbete kring OX390 mo…
Swedish 88.2 KB
2025-07-16 08:00 Swedish 6.7 MB
2025-07-16 08:00 English 6.6 MB
2025-06-30 17:30
Antal aktier och röster i Orexo
Swedish 76.3 KB
2025-06-30 17:30
Number of shares and votes in Orexo
English 76.6 KB
2025-06-25 11:38 Swedish 9.8 KB
2025-06-19 16:40 Swedish 9.9 KB
2025-06-18 18:00
Emission och återköp av C-aktier
Swedish 166.4 KB
2025-06-18 18:00
Issue and repurchase of class C shares
English 168.1 KB

Automate Your Workflow. Get a real-time feed of all Orexo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Orexo

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Orexo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-11 Nikolaj Arrild Sørensen Other Buy 2,460 35,178.00 SEK
2025-04-04 Nikolaj Arrild Sørensen Other Buy 3,500 47,530.00 SEK
2024-03-26 Fredrik Järrsten Other Buy 3,000 44,040.00 SEK
2023-11-24 Charlotte Vithlani Hansson Other Buy 3,000 44,640.00 SEK
2023-11-08 Fredrik Järrsten Other Buy 1,500 23,715.00 SEK
2023-02-24 Nikolaj Arrild Sørensen Other Buy 11,500 188,945.00 SEK
2023-01-27 Fredrik Järrsten Other Buy 4,500 79,695.00 SEK
2022-07-26 Michael Matly Other Buy 2,820 60,777.77 SEK
2022-07-21 Charlotte Vithlani Hansson Other Buy 3,000 61,500.00 SEK
2022-07-15 James Noble Other Buy 18,500 394,252.80 SEK

Peer Companies

AVACTA GROUP PLC Logo
Clinical-stage biotech developing targeted oncology drugs with a proprietary platform.
United Kingdom
AVCT
AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.